Site Search

Displaying results 551 - 560 of 893

"It has been a very positive experience" – an interview with the SME in IMI’s EU-AIMS project

News | 26/06/2017 |

Testimonials

Noldus Information Technology BV is a Dutch small and medium-sized enterprise (SME) with an important role in IMI’s EU-AIMS project, which aims to generate tools that will enhance our understanding of autism spectrum disorders. In an interview with the IMI Programme Office, Lucas ...

ENABLE scientists discover a new way to target drug-resistant bacteria

News | 24/06/2017 |

Success stories from projects

Scientists from IMI’s ENABLE project have found a new mechanism to target drug-resistant bacteria, opening up a promising new pathway for further research. The mechanism involves DNA gyrase, a well-known enzyme that is a target of already existing antibiotics. ENABLE scientists ...

Strategic Research Agenda

Content | 23/06/2017

The IMI2 Strategic Research Agenda (SRA) covers the period 2014 to 2020. It is fully aligned with both the EU’s health research priorities (which were decided by the European Parliament and the Council during the negotiation of Horizon 2020), and the World Health Organisation’s ...

IMI2 – Call 10

Content | 21/06/2017

IMI2 – Call 10 was launched on 21 December 2016 with the following topics: Understanding hypoglycaemia: the underlying mechanisms and addressing clinical determinants as well as consequences for people with diabetes by combining databases from clinical trials How big data could ...

IMI2 – Call 9

Content | 21/06/2017

IMI2 – Call 9 was launched on 27 April 2016 with the following topics: Addressing the clinical burden of Clostridium difficile infection (CDI): Evaluation of the burden, current practices and set-up of a European research platform (part of the IMI New Drugs for Bad Bugs (ND4BB) ...

IMI2 – Call 8

Content | 21/06/2017

IMI2 – Call 8 was launched on 18 December 2015 with the following topic: Ebola and other filoviral haemorrhagic fevers (Ebola+) programme: future outbreaks More information on the topic can be found in IMI’s press release and in the Call Text and our questions and answers ...

IMI2 – Call 7

Content | 21/06/2017

IMI2 – Call 7 was launched on 18 December 2015 with the following topics: Validation of translational imaging methods in drug safety assessment (TRISTAN) Identification of druggable targets modulating misfolded proteins in Alzheimer’s and Parkinson’s diseases Pathological neuron ...

Scientific publications by IMI

Content | 14/06/2017

Nature Microbiology, Vol. 6, p. 137, published online 28 January 2021 Meulien, P. (2021) Innovative Medicines Initiative plays the long game on research funding European Psychiatry, Vol. 50, pp. 57-59 Vaudano, E. (2018) Public–private partnerships as enablers of progress in the ...

IMI in the media

Content | 14/06/2017

expand all 2020 Neuroscience News (US), 12 December 2020 Genetic Differences Important for Alzheimer’s Diagnosis Horizon Magazine (EU), 11 December 2020 Five things you need to know about: mRNA vaccine safety Zorg Krant (The Netherlands), 23 November 2020 Ontdekking van ...

EPAD – revolutionising clinical trials for dementia

News | 06/06/2017 |

Success stories from projects

IMI’s EPAD project has an ambitious goal – to revolutionise the way we carry out clinical trials for treatments designed to prevent Alzheimer’s dementia. In an interview with the IMI Programme Office, project coordinators Craig Ritchie of the University of Edinburgh and Serge Van ...